SCHEMBL17437439

SCHEMBL17437439

Cn1c(-n2ncnc2N)nc2cnccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA5 O75582 9/20 0.45
▸ ATM Q13315 1/20 0.44
▸ NPC1 O15118 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ CDK2 P24941 2/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437404 0.84 RPS6KA5 (0.47) RPS6KA5ATMNPC1TP53MAPT
SCHEMBL17437517 0.82 RPS6KA5 (0.37) RPS6KA5ATMCDK2RPS6KB1ROCK1
SCHEMBL17437519 0.82 RPS6KA5 (0.37) RPS6KA5ATMCDK2RPS6KB1ROCK1
SCHEMBL17437386 0.81 RPS6KA5 (0.49) RPS6KA5ATMALDH1A1HSD17B10FGFR1
SCHEMBL17437575 0.80 RPS6KA5 (0.48) RPS6KA5ALDH1A1
SCHEMBL17437408 0.78 RPS6KA5 (0.41) RPS6KA5MAPTRAB9ASMN1; SMN2POLB
SCHEMBL17437495 0.78 HTR3A (0.41) RPS6KA5ATMMAPTPOLBKDM4E
SCHEMBL17437385 0.77 RPS6KA5 (0.51) RPS6KA5TP53MAPTKDM4EALDH1A1
SCHEMBL17437535 0.77 BRD4 (0.43) RPS6KA5MAPTPOLBKDM4EALDH1A1
SCHEMBL19233638 0.76 ATM (0.56) RPS6KA5ATMNPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885ATM 4652/4885NPC1 4168/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885ATM 4652/4885NPC1 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback